Sector News

Evonik to acquire PeroxyChem for $625 million

November 8, 2018
Chemical Value Chain

Evonik Industries says that it has signed an agreement with One Equity Partners to acquire PeroxyChem (Philadelphia, Pennsylvania) for $625 million. PeroxyChem is a manufacturer of hydrogen peroxide (H2O2) and peracetic acid (PAA). The company employs approximately 600 people, with eight production sites located mainly in North America, but also including Germany, Spain, and Thailand.

H2O2 and PAA acid are both oxidants that are used in a number of applications, such as a bleaching agent in the pulp industry, as a disinfectant for food processing, or for wastewater treatment. H2O2 is very environmentally friendly, as water is the only byproduct following its use. Hydrogen peroxide is increasingly used in attractive high-tech applications such as production of semiconductors, medical applications, and spacecraft technology. The H2O2 and PAA markets are characterized by an average annual growth rate of about 6%, according to Evonik.

“PeroxyChem will significantly strengthen our growth segment resource efficiency,” says Christian Kullmann, chairman of the executive board at Evonik. “We are expanding our portfolio of environmentally-friendly and high-growth specialty applications. Furthermore, we are getting an attractive business characterized by above-average growth, moderate capital intensity and low cyclicality,” Kullmann says.

PeroxyChem expects to earn revenues of approximately $300 million and an adjusted EBITDA of about $60 million in the 2018 fiscal year. The purchase price (enterprise value), including synergies, is about 7.8 times the annual adjusted EBITDA, or 10.4 times before synergies, Evonik says. The transaction is scheduled to be completed by mid-2019, subject to approval by the appropriate authorities.

Evonik says that it expects synergies across the combined global business of $20 million due to the complementary fit in operations, logistics, expansion of the product portfolio, and the launch of new technology. Synergies should be fully realized by 2022, according to Evonik.

“PeroxyChem is highly profitable. With an adjusted EBITDA margin of about 20%, profitability is constantly above Evonik’s current group margin,” says Ute Wolf, CFO, Evonik. “As a strong-growing and stable financing business, it also generates an attractive free cash flow,” she says.

By Michael Ravenscroft

Source: Chemical Week

comments closed

Related News

May 21, 2022

Sika opens new manufacturing plant in Bolivia 

Chemical Value Chain

Sika AG (Baar, Switzerland) has opened a new plant in Santa Cruz de la Sierra, thus doubling its production capacity for mortar and concrete admixtures in Bolivia. With this new facility in one of the country’s main industrial agglomerations, Sika is positioning itself for continued growth in the dynamic Bolivian construction market.

May 21, 2022

Chevron increases renewable fuel market share with REG acquisition

Chemical Value Chain

Chevron Corporation (NYSE: CVX) and Renewable Energy Group, Inc. (NASDAQ: REGI) (REG) announced on Monday a definitive agreement under which Chevron will acquire the outstanding shares of REG in an all-cash transaction valued at $3.15 billion, or $61.50 per share.

May 21, 2022

Lotte Chemical to invest $8 bn on hydrogen energy, battery materials by 2030

Chemical Value Chain

Lotte Chemical Corp. will invest 10 trillion won ($8 billion) on hydrogen and battery materials through 2030 to achieve annual revenue of 50 trillion won and carbon neutrality. The Korean chemical producer on Thursday unveiled its new corporate vision outlining key corporate strategies with focus on growth through hydrogen energy and battery materials businesses.